104 related articles for article (PubMed ID: 38751031)
1. Optimizing Clinical Translation of Bispecific T-cell Engagers through Context Unification with a Quantitative Systems Pharmacology Model.
Liao X; Qi T; Zhou J; Liu C; Cao Y
Clin Pharmacol Ther; 2024 May; ():. PubMed ID: 38751031
[TBL] [Abstract][Full Text] [Related]
2. Development of bispecific T cell engagers: harnessing quantitative systems pharmacology.
Qi T; Liao X; Cao Y
Trends Pharmacol Sci; 2023 Dec; 44(12):880-890. PubMed ID: 37852906
[TBL] [Abstract][Full Text] [Related]
3. A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell-Mediated Immune Response against EGFR-Expressing Tumors.
King LA; Toffoli EC; Veth M; Iglesias-Guimarais V; Slot MC; Amsen D; van de Ven R; Derks S; Fransen MF; Tuynman JB; Riedl T; Roovers RC; Adang AEP; Ruben JM; Parren PWHI; de Gruijl TD; van der Vliet HJ
Cancer Immunol Res; 2023 Sep; 11(9):1237-1252. PubMed ID: 37368791
[TBL] [Abstract][Full Text] [Related]
4. A Quantitative Systems Pharmacology Model of T Cell Engager Applied to Solid Tumor.
Ma H; Wang H; Sove RJ; Jafarnejad M; Tsai CH; Wang J; Giragossian C; Popel AS
AAPS J; 2020 Jun; 22(4):85. PubMed ID: 32533270
[TBL] [Abstract][Full Text] [Related]
5. Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma.
Kim JH; Kim DS; Park HS; Kim YS
Clin Immunol; 2023 Oct; 255():109755. PubMed ID: 37673224
[TBL] [Abstract][Full Text] [Related]
6. An optimal antitumor response by a novel CEA/CD3 bispecific antibody for colorectal cancers.
Wang N; Patel H; Schneider IC; Kai X; Varshney AK; Zhou L
Antib Ther; 2021 Apr; 4(2):90-100. PubMed ID: 34169228
[TBL] [Abstract][Full Text] [Related]
7. A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART
Betts A; Haddish-Berhane N; Shah DK; van der Graaf PH; Barletta F; King L; Clark T; Kamperschroer C; Root A; Hooper A; Chen X
AAPS J; 2019 May; 21(4):66. PubMed ID: 31119428
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model.
Ma H; Wang H; Sové RJ; Wang J; Giragossian C; Popel AS
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32859743
[TBL] [Abstract][Full Text] [Related]
9. Population dynamics of immunological synapse formation induced by bispecific T cell engagers predict clinical pharmacodynamics and treatment resistance.
Liu C; Zhou J; Kudlacek S; Qi T; Dunlap T; Cao Y
Elife; 2023 Jul; 12():. PubMed ID: 37490053
[TBL] [Abstract][Full Text] [Related]
10. Leveraging a physiologically-based quantitative translational modeling platform for designing B cell maturation antigen-targeting bispecific T cell engagers for treatment of multiple myeloma.
Yoneyama T; Kim MS; Piatkov K; Wang H; Zhu AZX
PLoS Comput Biol; 2022 Jul; 18(7):e1009715. PubMed ID: 35839267
[TBL] [Abstract][Full Text] [Related]
11. Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager.
Anbari S; Wang H; Zhang Y; Wang J; Pilvankar M; Nickaeen M; Hansel S; Popel AS
Front Pharmacol; 2023; 14():1163432. PubMed ID: 37408756
[TBL] [Abstract][Full Text] [Related]
12. Dawn of a new era of antibody-drug conjugates and bispecific T-cell engagers for treatment of multiple myeloma: a systematic review of literature.
Khattak ZE; Hashmi H; Khan SI; Aamir S; Arif U; Khan AI; Darwin A; Singh AD; Khouri J; Anwer F
Ann Hematol; 2021 Sep; 100(9):2155-2172. PubMed ID: 34318356
[TBL] [Abstract][Full Text] [Related]
13. Virtual Populations for Quantitative Systems Pharmacology Models.
Cheng Y; Straube R; Alnaif AE; Huang L; Leil TA; Schmidt BJ
Methods Mol Biol; 2022; 2486():129-179. PubMed ID: 35437722
[TBL] [Abstract][Full Text] [Related]
14. A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies.
Lameris R; Ruben JM; Iglesias-Guimarais V; de Jong M; Veth M; van de Bovenkamp FS; de Weerdt I; Kater AP; Zweegman S; Horbach S; Riedl T; Winograd B; Roovers RC; Adang AEP; de Gruijl TD; Parren PWHI; van der Vliet HJ
Cell Rep Med; 2023 Mar; 4(3):100961. PubMed ID: 36868236
[TBL] [Abstract][Full Text] [Related]
15. Quantitative systems pharmacology modeling sheds light into the dose response relationship of a trispecific T cell engager in multiple myeloma.
Abrams RE; Pierre K; El-Murr N; Seung E; Wu L; Luna E; Mehta R; Li J; Larabi K; Ahmed M; Pelekanou V; Yang ZY; van de Velde H; Stamatelos SK
Sci Rep; 2022 Jun; 12(1):10976. PubMed ID: 35768621
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Systems Pharmacology Modeling of PBMC-Humanized Mouse to Facilitate Preclinical Immuno-oncology Drug Development.
Ma H; Pilvankar M; Wang J; Giragossian C; Popel AS
ACS Pharmacol Transl Sci; 2021 Feb; 4(1):213-225. PubMed ID: 33615174
[TBL] [Abstract][Full Text] [Related]
17. Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.
Bai JPF; Earp JC; Pillai VC
AAPS J; 2019 Jun; 21(4):72. PubMed ID: 31161268
[TBL] [Abstract][Full Text] [Related]
18. Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model.
Ruiz-Martinez A; Gong C; Wang H; Sové RJ; Mi H; Kimko H; Popel AS
PLoS Comput Biol; 2022 Jul; 18(7):e1010254. PubMed ID: 35867773
[TBL] [Abstract][Full Text] [Related]
19. Understanding the General Principles of T Cell Engagement by Multiscale Computational Simulations.
Su Z; Almo SC; Wu Y
bioRxiv; 2023 Jun; ():. PubMed ID: 37333150
[TBL] [Abstract][Full Text] [Related]
20. Towards a platform quantitative systems pharmacology (QSP) model for preclinical to clinical translation of antibody drug conjugates (ADCs).
Scheuher B; Ghusinga KR; McGirr K; Nowak M; Panday S; Apgar J; Subramanian K; Betts A
J Pharmacokinet Pharmacodyn; 2023 Oct; ():. PubMed ID: 37787918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
